Quotient Sciences has successfully initiated a clinical study evaluating a novel drug product developed using AI
The protein design study aimed to validate AI-designed proteins with improved activity, stability and multifunctionality
The addition offers over 1,000 cell lines covering a range of tumours and tissues
Launched by Zifo, Pistoia Alliance, and Pharma Majors
AI/ML predictive models will be integrated into an electronic notebook to support workflows
Sign in to your account